Italy: market share of biosimilars 2017, by molecule
This statistic depicts the market share of biosimilars in Italy in 2017, by type. According to data, concerning G-CSF (Granulocyte-colony stimulating factor), the market share of biosimilar products accounted for 94 percent of the total market, which includes both originators and biosimilars. As regards epoetin, the share of consumption of biosimilars was of 69 percent.